WA
RMD icon

Whipplewood Advisors’s ResMed RMD Stock Holding History

Whipplewood Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.65K Buy
+43
New +$10.7K 0.01% 492
2025
Q3 		– Sell
-12
Closed -$3.1K – 979
2025
Q2 		$3.1K Sell
12
-2
-14% -$477 ﹤0.01% 795
2025
Q1 		$2.69K Buy
14
+2
+17% +$467 ﹤0.01% 825
2024
Q4 		$2.74K Buy
+12
New +$2.89K ﹤0.01% 816

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Whipplewood Advisors's RMD Position: Q1 2026 in Review

Whipplewood Advisors opened a new position in ResMed (RMD) in Q1 2026: 43 shares worth $9.65K. The stake represents 0.01% of the portfolio and ranks #492 among its holdings. This is a return to the name: Whipplewood Advisors previously reported a position in RMD as recently as Q2 2025.

Whipplewood Advisors first reported a position in RMD in Q4 2024 and has held it in 4 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Whipplewood Advisors held 43 shares of ResMed worth $9.65K as of Q1 2026.
  • ResMed was a new Whipplewood Advisors position in Q1 2026.
  • ResMed made up 0.01% of Whipplewood Advisors's portfolio in Q1 2026, its #492 holding.
  • Whipplewood Advisors first reported a position in ResMed in Q4 2024 and has held it in 4 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Whipplewood Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.